75 West Center Street
Provo, UT 84601
United States
801 345 1000
https://www.nuskin.com
版塊: Consumer Defensive
行業: Household & Personal Products
全職員工: 4,600
名稱 | 標題 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Mr. Steven J. Lund | Exec. Chairman | 827.03k | 無 | 1953 |
Mr. Ryan S. Napierski | Pres, CEO & Director | 1.46M | 806.24k | 1974 |
Mr. Mark H. Lawrence | Exec. VP & CFO | 918.58k | 無 | 1970 |
Dr. Joseph Y. Chang Ph.D. | Exec. VP & Chief Scientific Officer | 1.13M | 268.48k | 1953 |
Mr. Chayce David Clark | Exec. VP & Gen. Counsel | 540.92k | 140.25k | 1983 |
Mr. Ritch N. Wood | Exec. Advisor | 1.53M | 68.2k | 1966 |
Mr. D. Matthew Dorny | Legal Advisor | 687.56k | 2.02M | 1964 |
Ms. Mang Yee Tang | Exec. VP and Chief Global Growth & Customer Experience Officer | 796.45k | 無 | 1971 |
Mr. Blake M. Roney | Founder | 無 | 無 | 1959 |
Ms. Sandra N. Tillotson | Founder | 無 | 無 | 1957 |
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
截至 2022年6月1日 止,Nu Skin Enterprises, Inc. 的 ISS 管治質素評分為 3。 Pillar 分數正在審核中:3;董事會:1;股東權利:4;現金賠償:4。